by Ryan Klingler | Jan 29, 2025
Webinar De-risking clinical development and driving therapeutic innovation The power of RWD from EHRs Developing breakthrough therapies involves significant time, money, and uncertainty, and requires strong evidence-generation to prove value. Real-world data (RWD)...
by Ryan Klingler | Jan 29, 2025
Case study De-risking clinical development and driving therapeutic innovation for heart failure Heart failure (HF) impacts nearly 6.5 million Americans over the age of 20 in the US, with approximately 960,000 new cases each year. And HF readmission rates have...
by Ryan Klingler | Jan 29, 2025
Whitepaper Better device outcomes through better data Medical device companies face a unique challenge when attempting to study product performance post-launch – today’s real-world data (RWD) has a significant lack of detail on device use in clinical practice and...
by Ryan Klingler | Jan 29, 2025
Case study Assessing the comparative safety of novel pulmonary embolism treatments Each year, approximately 900,000 patients in the US are affected by a pulmonary embolism, a blood clot causing a blockage in one or more pulmonary arteries in the lungs. Despite the...
by Ryan Klingler | Jan 29, 2025
Webinar Enabling timely comparative effectiveness research Head-to-head analysis of GLP-1s for weight loss GLP-1 drugs have garnered extensive media coverage and celebrity endorsements over the past year for their ability to drive weight loss. With more than 73% of...
